|
Antidepressant Use in
Children, Adolescents, and Adults
Food and Drug Administration (FDA) asks manufacturers of all
antidepressant drugs to include in their labeling a boxed warning
and expanded warning statements that alert health care providers to
an increased risk of suicidality (suicidal thinking and behavior) in
children and adolescents being treated with these agents, and
additional information about the results of pediatric studies.
Current Information
Background Information
PDF files, marked with an icon
,
require the free
Adobe
Acrobat Reader.
Back
to Top
Back to Drug Information
Date created: March 22, 2004, updated November 3, 2004 |
|